Table 2.
Risk factor | Herpes zoster incidence (/1000 person-years) [95% CI]a | |
---|---|---|
General population | ||
Overall | 9·34 [8·78; 9·90] | |
Routine cohort | 9·45 [8·72; 10·18] | |
Catch-up cohort | 9·20 [8·55; 9·85] | |
Female | 10·55 [9·80; 11·3] | |
Male | 8·14 [7·49; 8·79] | |
Caucasian | 9·53 [8·95; 10·10] | |
Non-Caucasian | 5·79 [4·15; 7·43] | |
Non-smoker | 9·66 [8·94; 10·39] | |
Ex-smoker | 9·36 [8·54; 10·17] | |
Smoker | 8·01 [6·83; 9·20] | |
Patient populations | ||
Asthma | 11·20 [9·94; 12·45] | |
Immunocompromised | 15·48 [12·17; 18·79] | |
Immunosuppressed | 14·23 [10·92; 17·55] | |
History of herpes zoster | 10·78 [9·39; 12·17] |
Derived from simplified main effects model, assuming age, gender and ethnicity distribution as well as smoking behaviour reflective of the UK population. Assuming no other herpes zoster risk factors are present.